Bionano Genomics to Present at Several Upcoming Investor Conferences

Rhea-AI Summary

Bionano Genomics has announced its participation in two virtual investor conferences. Management will present at the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021, at 11:20 AM ET. Additionally, presentations will be available at the Maxim Group's Emerging Growth Conference from March 17-19, 2021. Webcasts will be accessible on Bionano's website for 30 days post-event.

SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the following investor conferences:

• Oppenheimer 31^st Annual Healthcare Conference, March 16-18, 2021
        º  Company management are scheduled to present on Wednesday, March 17, 2021 at 11:20 am ET.

• Maxim Group’s Emerging Growth Conference, March 17-19, 2021.
        º  The presentation will be available to all registered participants of the conference on March 17th - 19^th

Webcasts will be available following each event on the Events page in the Investors section of Bionano’s website at https://ir.bionanogenomics.com/ and will be archived on Bionano’s website for 30 days following the event.

About Bionano Genomics
Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano’s Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools. Bionano provides genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns. For more information, visit www.bionanogenomics.com or www.lineagen.com.

CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionanogenomics.com

Investor Relations Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
+1 (617) 430-7577
arr@lifesciadvisors.com

Media Contact:
Darren Opland, PhD
LifeSci Communications
+1 (617) 733-7668
darren@lifescicomms.com

FAQ

When will Bionano Genomics present at the Oppenheimer conference?

Bionano Genomics will present at the Oppenheimer 31st Annual Healthcare Conference on March 17, 2021, at 11:20 AM ET.

What events will Bionano Genomics participate in March 2021?

Bionano Genomics will participate in the Oppenheimer 31st Annual Healthcare Conference and Maxim Group's Emerging Growth Conference from March 17-19, 2021.

Where can I find the webcasts of Bionano Genomics presentations?

Webcasts of Bionano Genomics presentations will be available on their Events page in the Investors section of their website.

How long will the webcasts from Bionano Genomics be available?

The webcasts will be archived on Bionano's website for 30 days following each event.

What services does Bionano Genomics provide?

Bionano Genomics offers genome analysis tools and services, including the Saphyr system for structural variation detection and genetic testing for neurodevelopmental disorders.